Cardio Diagnostics Holdings CDIO
NASDAQ CDIO
$2.05 -0.16 (-7.24%)
As of: Aug 21, 2026 · 3:32 PM EDT

Cardio Diagnostics Holdings (CDIO) Total Debt (2022)

Cardio Diagnostics Holdings (CDIO) posted Total Debt of $433334.0 for Q3 2022.

Cardio Diagnostics Holdings (CDIO) Total Debt (2022) Analysis & Trends

Cardio Diagnostics Holdings has reported Total Debt for 1 years, with the latest figure at $433334.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 138.83 Bn 130.98 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.79 Bn 77.79 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 64.95 Bn 59.77 Bn 1.37 Bn -
4 Moderna 58.59 Bn 53.46 Bn 52.00 Mn 591.00 Mn
5 BeOne Medicines 41.93 Bn 36.83 Bn 1.53 Bn 1.07 Bn
6 Alnylam Pharmaceuticals 31.52 Bn 28.21 Bn 992.69 Mn -
7 BioNTech SE 27.98 Bn 9.58 Bn 668.28 Mn 770.36 Mn
8 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 546.77 Mn
9 Royalty Pharma 27.33 Bn 26.49 Bn - 9.34 Bn
10 Cardio Diagnostics Holdings 6.07 Mn 480,214.31 - -

Historic Data

Download Data
DateValue
Sep 30, 2022 433,334.00